Intravenous Immunoglobulin May Be an Effective Therapy for Refractory, Active Diffuse Cutaneous Systemic Sclerosis.

CONCLUSION: Our observational study suggests that IVIG may be an effective adjunctive therapy for active dcSSc in patients failing other therapies. PMID: 25433527 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Tags: J Rheumatol Source Type: research